OnKure Therapeutics Inc.

NASDAQ: OKUR · Real-Time Price · USD
2.53
-0.14 (-5.24%)
At close: Aug 15, 2025, 3:59 PM
2.44
-3.63%
After-hours: Aug 15, 2025, 07:38 PM EDT

OnKure Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-52.67M -35.31M -29.51M -39.77M
Depreciation & Amortization
662K 560K 387K 50K
Stock-Based Compensation
4.53M 199K 48K n/a
Other Working Capital
1.98M -1.71M 2.12M -2.8M
Other Non-Cash Items
316K n/a n/a 4.54M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-3.95M 6K 2.12M -2.8M
Operating Cash Flow
-51.12M -34.55M -26.95M -37.98M
Capital Expenditures
-52K -246K -1.13M -198K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -31.41M
Sales Maturities Of Investments
15.93M n/a 44.1M 8.23M
Other Investing Acitivies
n/a n/a -44.1M n/a
Investing Cash Flow
15.87M -246K -1.13M -23.38M
Debt Repayment
6M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
51.22M -723K -1.38M n/a
Financial Cash Flow
116.13M 53.13M 26.46M 132.41M
Net Cash Flow
80.89M 18.33M -1.62M 71.05M
Free Cash Flow
-51.17M -34.79M -28.09M -38.18M